Jean Jacques Bienaime - 12 Aug 2022 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
Chief Executive Officer, Director
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
12 Aug 2022
Net transactions value
-$664,630
Form type
4
Filing time
16 Aug 2022, 19:36:54 UTC
Previous filing
17 Jun 2022
Next filing
18 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Sale $379,000 -4,000 -1.2% $94.75 331,324 12 Aug 2022 Direct
transaction BMRN Common Stock Sale $285,630 -3,000 -0.91% $95.21 328,324 15 Aug 2022 Direct F1
holding BMRN Common Stock 247,533 12 Aug 2022 Shares held by Jean-Jacques Bienaime Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Trade made pursuant to a 10b5-1 plan executed on May 3, 2022.